Consumer health company Haleon plc (HLN) announced Tuesday the launch of Eroxon, the first-and-only FDA cleared gel available without a prescription for the treatment of erectile dysfunction (ED).
The product is now available for pre-order in the U.S. through Amazon and will be available at most major retailers in October 2024.
Eroxon is clinically proven to help men get an erection within 10 minutes to foster physical intimacy. The treatment stimulates nerve endings in the penis to help men with ED get and maintain an erection during sex.
Clinical study results show that Eroxon is safe and effective in men with ED. While ED can be caused by underlying physical conditions, psychological challenges such as stress, anxiety, depression, and other mental health issues may also contribute to ED, especially in younger men.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.